Agilent Technologies, Inc. $A Shares Sold by Prudential Financial Inc.

Prudential Financial Inc. cut its holdings in Agilent Technologies, Inc. (NYSE:A) by 7.4% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 201,951 shares of the medical research company’s stock after selling 16,234 shares during the period. Prudential Financial Inc.’s holdings in Agilent Technologies were worth $23,832,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Resona Asset Management Co. Ltd. lifted its holdings in shares of Agilent Technologies by 6.2% during the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock worth $11,631,000 after acquiring an additional 5,767 shares during the period. TrueMark Investments LLC acquired a new position in Agilent Technologies during the second quarter worth approximately $1,999,000. Fenimore Asset Management Inc increased its position in Agilent Technologies by 2.7% during the second quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock worth $21,346,000 after purchasing an additional 4,823 shares during the last quarter. Nuance Investments LLC raised its stake in Agilent Technologies by 13.5% during the second quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after purchasing an additional 9,628 shares during the period. Finally, Asset Management One Co. Ltd. boosted its holdings in shares of Agilent Technologies by 3.4% in the 2nd quarter. Asset Management One Co. Ltd. now owns 124,577 shares of the medical research company’s stock valued at $14,701,000 after purchasing an additional 4,152 shares during the last quarter. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 12,490 shares of the firm’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the completion of the sale, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. This trade represents a 27.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.26% of the company’s stock.

Agilent Technologies Trading Up 2.4%

Shares of A opened at $157.25 on Wednesday. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27. The stock’s 50-day moving average is $140.80 and its two-hundred day moving average is $126.03. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The stock has a market cap of $44.58 billion, a PE ratio of 36.91, a P/E/G ratio of 4.67 and a beta of 1.29.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, January 6th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. Agilent Technologies’s dividend payout ratio is presently 23.94%.

Analysts Set New Price Targets

A number of research firms have recently commented on A. Evercore ISI upped their price objective on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a report on Tuesday, October 7th. UBS Group upped their price target on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Tuesday. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. Bank of America boosted their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a report on Tuesday. Finally, Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $161.08.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.